| Dr Harry Rubinstein, MD | |
|
2020 Ogden Ave, Ste 140, Aurora, IL 60504-5894 | |
| (630) 851-1144 | |
| Not Available |
| Full Name | Dr Harry Rubinstein |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 50 Years |
| Location | 2020 Ogden Ave, Aurora, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154361954 | NPI | - | NPPES |
| 036051343 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 036051343 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tri Cities Dialysis Llc | Geneva, IL | Dialysis facility |
| Fox Valley Dialysis Ltd | Aurora, IL | Dialysis facility |
| Yorkville Dialysis Center Llc | Yorkville, IL | Dialysis facility |
| Dmj Home Health Services, Inc | Aurora, IL | Home health agency |
| Delnor Community Hospital | Geneva, IL | Hospital |
| Copley Memorial Hospital | Aurora, IL | Hospital |
| Central Dupage Hospital | Winfield, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fox Valley Medical Associates, Ltd. | 4183525454 | 14 |
News Archive
The findings are detailed in the journal Sports Medicine, in one of the marquee papers to emerge from the NCAA-DoD Concussion Assessment, Research and Education Consortium.
Women can encounter environmental factors that increase their risk of breast cancer at various periods of their physical development, beginning before birth and extending until menopause.
Columbia Engineering researchers report that Sofosbuvir-terminated RNA is more resistant to the proofreader of SARS-CoV-2, the virus that causes COVID-19, than Remdesivir-terminated RNA.
Resverlogix Corp. announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Most importantly RVX-208 has met its primary endpoint to increase the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL), often referred to as "good" cholesterol.
› Verified 3 days ago
| Entity Name | Fox Valley Medical Associates, Ltd. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629000245 PECOS PAC ID: 4183525454 Enrollment ID: O20040119000688 |
News Archive
The findings are detailed in the journal Sports Medicine, in one of the marquee papers to emerge from the NCAA-DoD Concussion Assessment, Research and Education Consortium.
Women can encounter environmental factors that increase their risk of breast cancer at various periods of their physical development, beginning before birth and extending until menopause.
Columbia Engineering researchers report that Sofosbuvir-terminated RNA is more resistant to the proofreader of SARS-CoV-2, the virus that causes COVID-19, than Remdesivir-terminated RNA.
Resverlogix Corp. announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Most importantly RVX-208 has met its primary endpoint to increase the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL), often referred to as "good" cholesterol.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harry Rubinstein, MD 2020 Ogden Ave, Ste 140, Aurora, IL 60504-5894 Ph: (630) 851-1144 | Dr Harry Rubinstein, MD 2020 Ogden Ave, Ste 140, Aurora, IL 60504-5894 Ph: (630) 851-1144 |
News Archive
The findings are detailed in the journal Sports Medicine, in one of the marquee papers to emerge from the NCAA-DoD Concussion Assessment, Research and Education Consortium.
Women can encounter environmental factors that increase their risk of breast cancer at various periods of their physical development, beginning before birth and extending until menopause.
Columbia Engineering researchers report that Sofosbuvir-terminated RNA is more resistant to the proofreader of SARS-CoV-2, the virus that causes COVID-19, than Remdesivir-terminated RNA.
Resverlogix Corp. announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Most importantly RVX-208 has met its primary endpoint to increase the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL), often referred to as "good" cholesterol.
› Verified 3 days ago
Dr. Simi Susan Rodney, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-892-4355 | |
Dr. Savitha Allam, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2000 Ogden Ave, Aurora, IL 60504 Phone: 866-565-8607 Fax: 630-898-3427 | |
Dr. Sharon C Ollee, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4100 Healthway Dr, Aurora, IL 60504 Phone: 630-851-3105 | |
Anne M Kinn, DO Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1221 N Highland Ave, Aurora, IL 60506 Phone: 630-801-2678 | |
Dr. Nidhi Tiwari, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2020 Ogden Ave Ste 400, Aurora, IL 60504 Phone: 630-692-5563 Fax: 630-692-5564 | |
Priyadarshini Verma, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6700 | |
Dr. Ravi K Prakash, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1221 N Highland Ave, Aurora, IL 60506 Phone: 630-859-8700 |